The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
Open accessAbstract
Drug nanocrystals are a versatile option for drug delivery purposes, and while the number of poorly soluble drug materials is all the time increasing, more research in this area is performed. Drug nanocrystals have a simple structure—a solid drug core is surrounded by a layer of stabilizing agent. However, despite the considerably simple structure, the selection of an appropriate stabilizer for a certain drug can be challenging. Mostly, the stabilizer selection is based purely on the requirement of physical stability, e.g., maintaining the nanosized particle size as long as possible after the formation of drug nanocrystals. However, it is also worth taking into account that stabilizer can affect the bioavailability in the final formulation via interactions with cells and cell layers. In addition, formation of nanocrystals is only one process step, and for the final formulation, more excipients are often added to the composition. The role of the stabilizers in the final formulation can be more than only stabilizing the nanocrystal particle size. A good example is the stabilizer’s role as cryoprotectant during freeze drying. In this review, the stabilizing effect, role of stabilizers in final nanocrystalline formulations, challenges in reaching in vitro–in vivo correlation with nanocrystalline products, and stabilizers’ effect on higher bioavailability are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00112-0 · Cited by 2,613
The use of mucoadhesive polymers in ocular drug delivery
LUDWIG, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.005 · Cited by 922
Merisko-Liversidge, E., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608
Vitamin E TPGS as a molecular biomaterial for drug delivery
Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586
Chiappetta, D. A., & Sosnik, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.022 · Cited by 567
The applications of Vitamin E TPGS in drug delivery
Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.006 · Cited by 523
Peltonen, L., & Hirvonen, J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01022.x · Cited by 405
Self-citationClinical impact of serum proteins on drug delivery
Kratz, F., & Elsadek, B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.028 · Cited by 375
Varma, M. V. S., & Panchagnula, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.003 · Cited by 361
Feng, S.-S., Mei, L., Anitha, P., Gan, C. W., & Zhou, W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.045 · Cited by 306
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo
Linn, M., Collnot, E.-M., Djuric, D., Hempel, K., Fabian, E., Kolter, K., & Lehr, C.-M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.025 · Cited by 242
A screening study of surface stabilization during the production of drug nanocrystals
Van Eerdenbrugh, B., Vermant, J., Martens, J. A., Froyen, L., Van Humbeeck, J., Augustijns, P., & Van den Mooter, G. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21563 · Cited by 242
Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels
Valo, H., Arola, S., Laaksonen, P., Torkkeli, M., Peltonen, L., Linder, M. B., Serimaa, R., Kuga, S., Hirvonen, J., & Laaksonen, T. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.023 · Cited by 241
Self-citationEnhanced solubility and dissolution rate of itraconazole by a solid dispersion technique
Jung, J.-Y., Yoo, S. D., Lee, S.-H., Kim, K.-H., Yoon, D.-S., & Lee, K.-H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00191-x · Cited by 221
Development of Curcumin Nanocrystal: Physical Aspects
Rachmawati, H., Shaal, L. A., Müller, R. H., & Keck, C. M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23335 · Cited by 160
Alvarez‐Lorenzo, C., Sosnik, A., & Concheiro, Á. (2011) · Current Drug Targets · doi:10.2174/138945011795906615 · Cited by 151
Valo, H., Kovalainen, M., Laaksonen, P. H., Häkkinen, M. R., Auriola, S. O. K., Peltonen, L., Linder, M. B., Järvinen, K., Hirvonen, J. J., & Laaksonen, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.016 · Cited by 150
Self-citationWin, K. Y., & Feng, S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.008 · Cited by 150
Understanding the structure and stability of paclitaxel nanocrystals
Deng, J., Huang, L., & Liu, F. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.013 · Cited by 143
Wang, J., Sun, J., Chen, Q., Gao, Y., Li, L., Li, H., Leng, D., Wang, Y., Sun, Y. H., Jing, Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.019 · Cited by 143
Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension
Ahuja, B. K., Jena, S. K., Paidi, S. K., Bagri, S., & Suresh, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.003 · Cited by 139
Multifunctional Hydrophobin: Toward Functional Coatings for Drug Nanoparticles
Valo, H., Laaksonen, P. H., Peltonen, L. J., Linder, M. B., Hirvonen, J. J., & Laaksonen, T. (2010) · ACS Nano · doi:10.1021/nn9017558 · Cited by 135
Self-citationBecket, G., Schep, L. J., & Tan, M. Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00382-2 · Cited by 133
Twenty years of drug nanocrystals: Where are we, and where do we go?
Müller, R. H., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.09.012 · Cited by 123
Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation
Lü, Y., Wang, Z., Li, T., McNally, H. A., Park, K., & Sturek, M. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.018 · Cited by 121
Frank, K. J., Westedt, U., Rosenblatt, K. M., et al. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23979 · Cited by 108
Zhang, K., Yu, H., Luo, Q., Yang, S., Lin, X., Zhang, Y. X., Tian, B., & Tang, X. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.03.002 · Cited by 106
Poloxamine-based nanomaterials for drug delivery
Alvarez‐Lorenzo, C. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e102 · Cited by 99
Amorphous Drug Nanosuspensions. 2. Experimental Determination of Bulk Monomer Concentrations
Lindfors, L., Forssén, S., Skantze, P., et al. (2005) · Langmuir · doi:10.1021/la052367t · Cited by 98
Beirowski, J., Inghelbrecht, S., Ariën, A., & Gieseler, H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22425 · Cited by 93
Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals
Zuo, B., Sun, Y. H., Li, H., Liu, X., Zhai, Y., Sun, J., & He, Z. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.021 · Cited by 85
Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions
Kim, S., & Lee, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.010 · Cited by 78
Sharma, S., Verma, A., Pandey, G., Mittapelly, N., & Mishra, P. R. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.08.005 · Cited by 77
Stable carbamazepine colloidal systems using the cosolvent technique
Douroumis, D., & Fahr, A. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.12.003 · Cited by 77
Kurakula, M., Sobahi, T. R., Abdelaal, M. Y., & El-Helw, A.-R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77731 · Cited by 76
Sun, W., Tian, W., Zhang, Y., He, J., Mao, S., & Fang, L. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.07.006 · Cited by 72
Ochi, M., Kawachi, T., Toita, E., Hashimoto, I., Yuminoki, K., Onoue, S., & Hashimoto, N. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.022 · Cited by 70
Sigfridsson, K., Forssén, S., den Hollander, P. H. C., Skantze, U., & de Verdier, J. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.02.008 · Cited by 69
Lu, J., Zhao, W., Liu, H., Marquez, R. T., Huang, Y., Zhang, Y., Li, J., Xie, W., Venkataramanan, R., Xu, L., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.016 · Cited by 62
Guo, M., Fu, Q., Wu, C., Guo, Z., Li, M., Sun, J., He, Z., & Yang, L. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.02.039 · Cited by 62
Higashino, H., Hasegawa, T., Yamamoto, M., Matsui, R., Masaoka, Y., Kataoka, M., Sakuma, S., & Yamashita, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400465p · Cited by 61
Gadadare, R., Mandpe, L., & Pokharkar, V. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0267-8 · Cited by 49
Surwase, S. A., Itkonen, L., Aaltonen, J., Saville, D. J., Rades, T., Peltonen, L., & Strachan, C. J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.06.005 · Cited by 47
Self-citationWang, Y., Guo, M., Yu, L., Ding, L.-Y., Ron, W.-T., Liu, Y., Song, F.-F., & Yu, S. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/49/495103 · Cited by 41
Gao, L., Liu, G., Ma, J., Wang, X., Wang, F., Wang, H., & Sun, J. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.02.016 · Cited by 38
Kumar, B. S., Saraswathi, R., Kumar, K. V., Jha, S. K., Venkatesh, D. P., & Dhanaraj, S. A. (2013) · Drug Delivery · doi:10.3109/10717544.2013.840690 · Cited by 37
Yi, Y., Tu, L., Hu, K., Wu, W., & Feng, J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.04.054 · Cited by 36
Ge, Z.-Q., Du, X.-Y., Huang, X., & Qiao, B. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.08.001 · Cited by 33
Raula, J., Rahikkala, A., Halkola, T., Pessi, J., Peltonen, L., Hirvonen, J. J., Järvinen, K., Laaksonen, T., & Kauppinen, E. I. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.036 · Cited by 32
Self-citationHydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs
Lee, M. K., Kim, S., Ahn, C.-H., & Lee, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.09.041 · Cited by 32
Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor
Danhier, F., Učakar, B., Vanderhaegen, M.-L., Brewster, M. E., Ariën, T., & Véronique Préat, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.014 · Cited by 25
Tang, X.-J., Ying-hua, F., Meng, Q.-H., Li, L.-M., Ying, X., Han, M. Y., He, Q., Yang, B., Zeng, S., Hu, Y., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.058 · Cited by 24
Darville, N., Saarinen, J. K. S., Isomäki, A., Khriachtchev, L. Y., Cleeren, D., Sterkens, P., van Heerden, M., Annaert, P., Peltonen, L., Santos, H. A., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.003 · Cited by 22
Self-citation
Cited by
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Pharmaceutical nanocrystals: production by wet milling and applications
Malamatari, M., Taylor, K. M. G., Malamataris, S., Douroumis, D., & Kachrimanis, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.016 · Cited by 369
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective
Quispe, C., Herrera-Bravo, J., Javed, Z., Khan, K., Raza, S., Gulsunoglu-Konuskan, Z., Daştan, S. D., Sytar, O., Martorell, M., Sharifi-Rad, J., et al. (2022) · BioMed Research International · doi:10.1155/2022/1375892 · Cited by 92
Metadata
- Authors
- Tuomela, A., Hirvonen, J., & Peltonen, L.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2016-05-20
- Volume
- 8
- Issue
- 2
- Pages
- 16
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2408652960
- Cited by
- 282
- References
- 54
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.